Roland G Asmar

Summary

Affiliation: The Cardiovascular Institute
Country: France

Publications

  1. ncbi request reprint Validation of two devices for self-measurement of brachial blood pressure according to the International Protocol of the European Society of Hypertension: the SEINEX SE-9400 and the Microlife BP 3AC1-1
    Jirar A Topouchian
    The Cardiovascular Institute, Paris, France
    Blood Press Monit 10:325-31. 2005
  2. ncbi request reprint Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study
    R Asmar
    L Institut CardioVasculaire, Paris, France
    J Hypertens 19:813-8. 2001
  3. ncbi request reprint Benefits of blood pressure reduction in elderly patients
    Roland Asmar
    The Cardiovascular Institute, Paris, France
    J Hypertens Suppl 21:S25-30. 2003
  4. ncbi request reprint Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension
    Roland Asmar
    The Cardiovascular Institute, Paris, France
    J Renin Angiotensin Aldosterone Syst 3:176-80. 2002
  5. ncbi request reprint [Cardioprotective effects of anti-hypertensive medications]
    Roland G Asmar
    Institut cardiovasculaire, Paris, France
    Curr Med Res Opin 21:S17-21. 2005
  6. pmc Targeting effective blood pressure control with angiotensin receptor blockers
    R Asmar
    The Cardiovascular Institute, Paris, France
    Int J Clin Pract 60:315-20. 2006
  7. ncbi request reprint Benefits of blood pressure reduction in elderly patients
    Roland Asmar
    The Cardiovascular Institute, Paris, France
    J Hypertens Suppl 21:S25-30. 2003
  8. ncbi request reprint Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and Type 2 diabetes mellitus
    R Asmar
    L Institut CardioVasculaire, Paris, 75016, France
    J Renin Angiotensin Aldosterone Syst 2:S8-11. 2001
  9. ncbi request reprint [Blood pressure. Regulation and epidemiology. Standard measures and values]
    Roland Asmar
    Institut cardiovasculaire, 2, rue du Docteur Blanche, 75016 Paris, France
    Nephrol Ther 3:163-84. 2007
  10. ncbi request reprint High blood pressure and associated cardiovascular risk factors in France
    R Asmar
    L Institut CardioVasculaire, Paris, France
    J Hypertens 19:1727-32. 2001

Collaborators

Detail Information

Publications34

  1. ncbi request reprint Validation of two devices for self-measurement of brachial blood pressure according to the International Protocol of the European Society of Hypertension: the SEINEX SE-9400 and the Microlife BP 3AC1-1
    Jirar A Topouchian
    The Cardiovascular Institute, Paris, France
    Blood Press Monit 10:325-31. 2005
    ....
  2. ncbi request reprint Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study
    R Asmar
    L Institut CardioVasculaire, Paris, France
    J Hypertens 19:813-8. 2001
    ..To evaluate the ability of an antihypertensive therapy to improve arterial stiffness as assessed by aortic pulse wave velocity (PWV) in a large population of hypertensive patients...
  3. ncbi request reprint Benefits of blood pressure reduction in elderly patients
    Roland Asmar
    The Cardiovascular Institute, Paris, France
    J Hypertens Suppl 21:S25-30. 2003
    ..Although the therapeutic goal is < 140/90 mmHg, a decrease of 20-30 mmHg in SBP, even if the overall goal is not achieved, is associated with improved prognosis...
  4. ncbi request reprint Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension
    Roland Asmar
    The Cardiovascular Institute, Paris, France
    J Renin Angiotensin Aldosterone Syst 3:176-80. 2002
    ..These properties of telmisartan suggest that it may improve cardiovascular outcome in this patient population...
  5. ncbi request reprint [Cardioprotective effects of anti-hypertensive medications]
    Roland G Asmar
    Institut cardiovasculaire, Paris, France
    Curr Med Res Opin 21:S17-21. 2005
    ....
  6. pmc Targeting effective blood pressure control with angiotensin receptor blockers
    R Asmar
    The Cardiovascular Institute, Paris, France
    Int J Clin Pract 60:315-20. 2006
    ..The future use of ARBs is likely to involve a growing emphasis on compound-specific data, with regard to the antihypertensive efficacy and pleiotropic protective actions of agents...
  7. ncbi request reprint Benefits of blood pressure reduction in elderly patients
    Roland Asmar
    The Cardiovascular Institute, Paris, France
    J Hypertens Suppl 21:S25-30. 2003
    ..Although the therapeutic goal is < 140/90 mmHg, a decrease of 20-30 mmHg in SBP, even if the overall goal is not achieved, is associated with improved prognosis...
  8. ncbi request reprint Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and Type 2 diabetes mellitus
    R Asmar
    L Institut CardioVasculaire, Paris, 75016, France
    J Renin Angiotensin Aldosterone Syst 2:S8-11. 2001
    ....
  9. ncbi request reprint [Blood pressure. Regulation and epidemiology. Standard measures and values]
    Roland Asmar
    Institut cardiovasculaire, 2, rue du Docteur Blanche, 75016 Paris, France
    Nephrol Ther 3:163-84. 2007
    ..This should lead to improve therapeutical approaches of cardiovascular diseases and consequently, to a better management of hypertensive patients...
  10. ncbi request reprint High blood pressure and associated cardiovascular risk factors in France
    R Asmar
    L Institut CardioVasculaire, Paris, France
    J Hypertens 19:1727-32. 2001
    ..To estimate, with respect to age and gender, the prevalence of high blood pressure (BP) in treated and non-treated subjects and its association with other cardiovascular risk factors...
  11. ncbi request reprint Reference values for clinic pulse pressure in a nonselected population
    R Asmar
    Institut cardiovasculaire, Paris, France
    Am J Hypertens 14:415-8. 2001
    ....
  12. ncbi request reprint Validation of the OMRON M7 (HEM-780-E) blood pressure measuring device in a population requiring large cuff use according to the International Protocol of the European Society of Hypertension
    Ramzi N El Feghali
    The Cardiovascular Institute, Paris, France
    Blood Press Monit 12:173-8. 2007
    ..Validation studies are usually performed in the general population using a standard-size cuff. The aim of this study was to assess the accuracy of the Omron M7 device in a population with an arm circumference ranging from 32 to 42 cm...
  13. pmc Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension
    Jalil Belghazi
    The Cardiovascular Institute, Paris, France
    Vasc Health Risk Manag 3:389-400. 2007
    ....
  14. ncbi request reprint Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT)
    Jirar A Topouchian
    The Cardiovascular Institute, Paris, France
    Blood Press Monit 11:165-71. 2006
    ....
  15. pmc Arterial stiffness and pharmacological interventions--the TRanscend arterial stiffNess Substudy (TRANS study)
    Jirar Topouchian
    The Cardiovascular Institute, Paris, France
    Vasc Health Risk Manag 3:381-7. 2007
    ..When completed, the results of the TRANS substudy will show whether the beneficial effects of treatment with telmisartan on cardiovascular outcome may be related to an improvement in arterial stiffness...
  16. pmc Effect of candesartan cilexetil on diabetic and non-diabetic hypertensive patients: meta-analysis of five randomized double-blind clinical trials
    Ramzi E L Féghali
    The Cardiovascular Institute, Paris, France
    Vasc Health Risk Manag 3:165-71. 2007
    ..To study the effect of candesartan cilexetil (CC) in the management of blood pressure (BP) in diabetic and non-diabetic hypertensive patients...
  17. ncbi request reprint Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period
    Athanase Benetos
    Centre d Investigations Préventives et Cliniques, Paris, France
    Circulation 105:1202-7. 2002
    ..The aim of the present longitudinal study was to compare the progression of aortic stiffness over a 6-year period in treated hypertensive subjects and normotensive subjects, and to evaluate the determinants of this progression...
  18. ncbi request reprint A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations
    Guillaume Bobrie
    Department of Hypertension Hôpital Européen Georges Pompidou, Paris, France
    Am J Hypertens 18:1482-8. 2005
    ..The objective of this prospective, randomized, open-label, blinded-endpoint study was to compare the antihypertensive efficacy of valsartan 80 mg v irbesartan 150 mg when combined with hydrochlorothiazide (HCTZ) 12.5 mg...
  19. ncbi request reprint Gender influence on the dose-ranging of a low-dose perindopril-indapamide combination in hypertension: effect on systolic and pulse pressure
    Michel E Safar
    Medecine Interne 1, Hopital Broussais, Paris, France
    J Hypertens 20:1653-61. 2002
    ..A low-dose combination of perindopril (Per) and indapamide (Ind) has been shown to reduce more SBP than atenolol for the same DBP reduction. However, the possible influence of gender on this finding has never been tested...
  20. ncbi request reprint Pulse pressure: an important tool in cardiovascular pharmacology and therapeutics
    Roland Asmar
    Cardiovascular Institute, Paris, France
    Drugs 63:927-32. 2003
    ..Finally, on the basis of large-scale intervention trials, PP seems to be an appropriate tool for studies of clinical pharmacology and therapeutics in the fields of hypertension, congestive heart failure and other cardiovascular diseases...
  21. pmc A large scale study of angiotensin II inhibition therapy in an elderly population: the CHANCE study
    Roland Asmar
    The Cardiovascular Institute, Paris, France
    Vasc Health Risk Manag 2:317-23. 2006
    ..In summary, CC 8-16 mg once daily was effective and well tolerated in the management of arterial hypertension in elderly subjects...
  22. ncbi request reprint Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study
    Pierre Boutouyrie
    Department of Pharmacology and INSERM EMI 0107, Hopital Europeen Georges Pompidou, Paris, France
    Hypertension 39:10-5. 2002
    ..This study provides the first direct evidence in a longitudinal study that aortic stiffness is an independent predictor of primary coronary events in patients with essential hypertension...
  23. ncbi request reprint Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study
    Michel Marre
    Hopital Bichat, Service de Diabétologie et d Endocrinologie, Paris, France
    J Hypertens 22:1613-22. 2004
    ....
  24. ncbi request reprint Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT
    Mohamed A El Assaad
    The Cardiovascular Institute, Paris, France
    Blood Press Monit 8:127-33. 2003
    ..Two devices for self-measurement of blood pressure at the brachial artery-the Omron M5-I and the Omron 705IT-were evaluated according to the international protocol of the European Society of Hypertension...
  25. ncbi request reprint Reversal of left ventricular hypertrophy with the ACE inhibitor moexipril in patients with essential hypertension
    Roland Asmar
    Institut de Recherche et de Formation CardioVasculaire, Paris, France
    Acta Cardiol 57:31-2. 2002
  26. ncbi request reprint Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications
    Athanase Benetos
    IPC Center, Paris, France
    Am J Hypertens 15:1101-8. 2002
    ..However, relationships between these three alterations of the arterial wall remain to be explored...
  27. ncbi request reprint Regression of left ventricular hypertrophy with moexipril, an angiotensin-converting enzyme inhibitor, in hypertensive patients
    Fady Sayegh
    L Institut Cardio Vasculaire, 2 rue du Dr Blanche, 75016 Paris, France
    Am J Ther 12:3-8. 2005
    ..The result compares favorably with results previously obtained in trials of similar duration with other ACE inhibitors...
  28. pmc Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy
    Roland Asmar
    Institut cardiovasculaire, Paris, France
    Vasc Health Risk Manag 3:371-80. 2007
    ..Ambulatory blood pressure (BP) is more sensitive than office BP and is highly correlated with the left ventricular mass (LVM) of hypertensive patients with left ventricular hypertrophy (LVH)...
  29. ncbi request reprint Angiotensin-converting enzyme D/I gene polymorphism and age-related changes in pulse pressure in subjects with hypertension
    Michel E Safar
    Diagnosis Center, Hotel Dieu Hospital, Paris, France
    Arterioscler Thromb Vasc Biol 24:782-6. 2004
    ....
  30. doi request reprint Validation of three automatic devices for self-measurement of blood pressure according to the International Protocol: The Omron M3 Intellisense (HEM-7051-E), the Omron M2 Compact (HEM 7102-E), and the Omron R3-I Plus (HEM 6022-E)
    Roland Asmar
    Centre de Médecine CardioVasculaire, Paris, France
    Blood Press Monit 15:49-54. 2010
    ..The Omron M3 Intellisense and the Omron M2 Compact measures blood pressure (BP) at the brachial level; the Omron R3-I Plus measures BP at the wrist level...
  31. doi request reprint Endpoints in clinical trials: does evidence only originate from 'hard' or mortality endpoints?
    Roland Asmar
    Centre de Médecine CardioVasculaire, Paris, France
    J Hypertens Suppl 27:S45-50. 2009
    ..In this article we overview the advantages and disadvantages of morbidity/mortality trials and 'hard' versus 'soft' endpoints. We also considered the relevance of analyzing not only primary endpoints but also secondary endpoints...
  32. doi request reprint Validation of three professional devices measuring office blood pressure according to three different methods: the Omron BP10, the Omron HBP T105 and the Pic Indolor Professional
    Roland Asmar
    Centre de Médecine CardioVasculaire, Paris, France
    J Hypertens 28:452-8. 2010
    ..The Omron BP10 uses the oscillometric method, the Omron HBP T105 (module HBP-M3600) uses the smart inflation mode and high-speed measurement and the Pic Indolor Professional check is a hybrid sphygmomanometer...
  33. ncbi request reprint Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol
    Gerard M London
    Hopital Manhes, Fleury Merogis, France
    J Am Coll Cardiol 43:92-9. 2004
    ....
  34. ncbi request reprint Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects
    Nicola De Luca
    Universita degli Studi Federico II, Naples, Italy
    J Hypertens 22:1623-30. 2004
    ..The objective was to determine whether changes in LVM under drug treatment was preferentially associated with changes in central or brachial SBP and PP...